A. Riso

Other targeted drugs in melanoma.

R. Rosell, M. Santarpia, J. Rodon, 2015, Annals of translational medicine.

Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete response

R. Rosell, M. Santarpia, M. Fernández-Figueras, 2016, Oncotarget.

Melanoma: oncogenic drivers and the immune system.

R. Rosell, M. Santarpia, S. Pilotto, 2015, Annals of translational medicine.

Immune checkpoint inhibitors: therapeutic advances in melanoma.

I. Márquez-Rodas, A. Berrocal, A. Soria, 2015, Annals of translational medicine.

Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer.

R. Rosell, S. Viteri, F. Barrón, 2015, Translational lung cancer research.

PSA values as a surrogate of overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC) treated with second-line (2L) chemotherapy (CT).

M. Molina, E. Richardet, A. Riso, 2014 .